Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)-Reference-Cited by-同舟云学术

Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (Lomustine)

Published:2009-12 Issue:4 Volume:7 Page:244-255
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:

Author:

Hosoya K.,Lord L. K.,Lara-Garcia A.,Kisseberth W. C.,London C. A.,Couto C. G.

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5829.2009.00197.x/fullpdf

Reference29 articles.

1. Combination chemotherapy with l-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma;Saba;Journal of Veterinary Internal Medicine,2007

2. CCNU for the treatment of dogs with histiocytic sarcoma;Skorupski;Journal of Veterinary Internal Medicine,2007

3. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004);Risbon;Journal of Veterinary Internal Medicine,2006

4. CCNU in the treatment of canine epitheliotropic lymphoma;Williams;Journal of Veterinary Internal Medicine,2006

5. Treatment of canine mast cell tumors with CCNU (lomustine);Rassnick;Journal of Veterinary Internal Medicine,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

2. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23

3. Metronomic Chemotherapy;Therapeutic Strategies in Veterinary Oncology;2023-08-23

4. Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs;Veterinary and Comparative Oncology;2022-03-11

5. Biochemical, functional, and histopathologic characterization of lomustine-induced liver injury in dogs;American Journal of Veterinary Research;2020-10